Global Tumor Ablation Market Report 2024: Case Studies on Radiofrequency Ablation Analysis and Ablation of Localized Renal Tumor

Company Logo

Global Tumor Ablation Market

Global Tumor Ablation Market

Dublin, June 05, 2024 (GLOBE NEWSWIRE) -- The "Global Tumor Ablation Market Size, Share & Trends by Technology, Product, Mode, Cancer, End User & Region - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

The global tumor ablation market is projected to reach USD 1.4 billion by 2029 from USD 0.8 billion in 2024, at a CAGR of 10% from 2024 to 2029. Aging population, coupled with a rise in tumor cases such as osteoid osteoma, has increased the demand for these products. Moreover, increased awareness of ablation procedures over conventional procedures has driven demand for tumor ablation systems.

The radiofrequency ablation segment of technology segment held the largest share of the market in 2023

The tumor ablation market is segmented based on technology into radiofrequency ablation, microwave ablation, laser ablation, high-intensity focused ultrasound (HIFU), cryoablation, and irreversible electroporation (IRE). As the global population ages, conditions affecting the major organs are more prevalent, contributing to the demand for supportive and rehabilitative solutions. Additionally, advancements in technology have led to the development and incorporation of ablation systems, expanding the market further.

The generators segment is projected to register the highest CAGR during the forecast period.

Based on product type, the tumor ablation market is segmented into generators and probes/electrodes. The generators segment accounted for the largest market share in 2023. The probes/electrodes market is witnessing growth due to recent regulatory approvals of ablation systems and favourable reimbursement policies. The probes/electrodes have undergone certain technological advancements supporting the precise ablation procedure. The growing awareness of the importance of early detection and the shift towards value-based healthcare has also contributed to the increasing demand for soft and elastic braces and its growing market.

The laparoscopic ablation segment for mode of treatment segment is projected to register a significant CAGR during the forecast period.

Based on mode of treatment, the tumor ablation market is segmented into surgical ablation, laparoscopic ablation, and percutaneous ablation . The surgical ablation segment accounted for the largest market share in 2023. Growing investments in R&D and rising demand for less invasive alternative is driving the growth of this segment.

The liver cancer segment for application segment held held the largest share of the market in 2022.

Based on application, the tumor ablation market is segmented into liver cancer, lung cancer, bone cancer, kidney cancer, and other applications. The liver cancer was the major segment, accounted for the largest share of the tumor ablation market in 2023. Rising cancer incidence is supported by the increasing aging population. This ultimately drives the adoption of tumor ablation systems. A rising number of campaigns for the early detection of symptoms is also contributing to the increasing utilization of ablation treatment in end-user facilities.

The cancer care center segment for the end user segment is projected to register a significant CAGR during the forecast period.

The tumor ablation market is segmented by end user into hospitals and clinics, cancer care centers, and ambulatory surgery centers. The hospitals and clinics segment accounted for a significant market share in 2023. The emphasis on non- and minimally invasive treatment among the geriatric population helps the growing preference for ablation treatment solutions, driving the integration of tumor ablation systems into hospital settings.

The market in the North America region is expected to witness the highest growth during the forecast period.

The North America tumor ablation market is expected to hold a major share during the forecast period. The US market holds a dominating position in the North American market, primarily due to the region's high healthcare spending, rising prevalence of target diseases, a growing number of non-invasive treatments, and technological advancements in ablation systems.

This report provides insights on the following :

• Analysis of key drivers (increasing cancer incidence and rising geriatric population, rising focus on minimally invasive procedures, technological advancements in the field of tumor ablation, rising number of awareness campaigns and early detection), restraints (high cost of tumor ablation systems, unfavorable reimbursement scenario), opportunities (rising healthcare expenditure across emerging countries, increasing number of hospitals), and challenges (rising adoption of refurbished tumor ablation systems, hospital budget cuts) influencing the growth of the tumor ablation market

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the tumor ablation market

• Market Development: Comprehensive information about lucrative markets-the report analyses the tumor ablation market across varied regions.

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the tumor ablation market

• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players - such as Johnson & Johnson (US), Medtronic Plc (Ireland), Stryker Corporation (US), Varian Medical Systems, Inc. (US), Olympus (Japan), AngioDynamics, Inc. (US), Boston Scientific Corporation (US) among others.

Key Attributes:

Report Attribute	Details
No. of Pages	192
Forecast Period	2024 - 2029
Estimated Market Value (USD) in 2024	$0.8 Billion
Forecasted Market Value (USD) by 2029	$1.4 Billion
Compound Annual Growth Rate	10.0%
Regions Covered	Global

Key Topics Covered:

Executive Summary

• Tumor Ablation Market, Technology, 2024 vs. 2029 (USD Million)

• Tumor Ablation Market, by Product Type, 2024 vs. 2029 (USD Million)

• Tumor Ablation Market, by Mode of Treatment, 2024 vs. 2029 (USD Million)

• Tumor Ablation Market, by Application, 2024 vs. 2029 (USD Million)

• Tumor Ablation Market, by End-user, 2024 vs. 2029 (USD Million)

• Tumor Ablation Market: Geographic Snapshot

Premium Insights

• Tumor Ablation Market Overview -Rising Prevalence of Cancer to Drive Market Growth

• North America: Tumor Ablation Market, by Technology -Microwave Ablation Segment to Register Significant Growth in North America During Forecast Period

• Europe: Tumor Ablation Market, by Application -Liver Cancer Segment to Dominate Market in Europe During Forecast Period

• Asia-Pacific: Tumor Ablation Market, by End-user -Hospitals & Clinics Segment to Continue to Hold Largest Share in Asia-Pacific Market

• Geographic Snapshot of Tumor Ablation Market - China to Witness Highest Growth During Forecast Period

Market Dynamics

Drivers

• Increasing Cancer Incidence and Rising Geriatric Population

• Rising Focus on Minimally Invasive Procedures

• Technological Advancements in Field of Tumor Ablation

• Rising Number of Awareness Campaigns and Early Detection

Restraints

• High Cost of Tumor Ablation Systems

• Unfavorable Regulatory Scenario

Opportunities

• Rising Healthcare Expenditure Across Emerging Economies

• Increasing Number of Hospitals

Challenges

• Rising Adoption of Refurbished Tumor Ablation Systems

• Hospital Budget Cuts

Case Study Analysis

• Case Study 1: Radiofrequency Ablation Analysis Case Study

• Case Study 2: Ablation of Localized Renal Tumor

Companies Featured

• Medtronic

• Johnson & Johnson Medtech (Ethicon)

• Stryker Corporation

• Varian Medical Systems, Inc.

• Angiodynamics, Inc.

• Boston Scientific Corporation

• Edap Tms SA

• Mermaid Medical

• Canyon Medical Inc.

• Olympus Corporation

• Chongqing Haifu Medical Technology Co. Ltd.

• Merit Medical Systems, Inc.

• Bioventus Inc.

• Icecure Medical Ltd.

• Conmed Corporation

• Monteris Medical

• Mianyang Sonic Electronic

• Rf Medical

• Minimax Medical Holding Group

• Sonablate

• Eco Medical Technology (Nanjing) Co. Ltd.

• Starmed Co. Ltd.

• Surgnova

• Creo Medical

• Medsphere Shanghai

For more information about this report visit https://www.researchandmarkets.com/r/hzsvtz

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Global Tumor Ablation Market

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900